Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity
Objectives: Currently there are no standard biomarkers of head and neck squamous cell carcinoma (HNSCC) response to therapy. This is, due to a lack of adequate predictive tumor models. To this end, we established cancer organoid lines from individual patient's tumors, and characterized their gr...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Ltd
2018
|
Subjects: | |
Online Access: | View Fulltext in Publisher |